LOW-DENSITY-LIPOPROTEIN APHERESIS IMPROVES REGIONAL MYOCARDIAL PERFUSION IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND EXTENSIVE CORONARY-ARTERY DISEASE - THE LDL-APHERESIS ATHEROSCLEROSIS REGRESSION STUDY (LAARS)
Wrm. Aengevaeren et al., LOW-DENSITY-LIPOPROTEIN APHERESIS IMPROVES REGIONAL MYOCARDIAL PERFUSION IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND EXTENSIVE CORONARY-ARTERY DISEASE - THE LDL-APHERESIS ATHEROSCLEROSIS REGRESSION STUDY (LAARS), Journal of the American College of Cardiology, 28(7), 1996, pp. 1696-1704
Objectives. In a randomized study we evaluated the effect of biweekly
low density lipoprotein (LDL) apheresis plus simvastatin versus medica
tion alone on regional myocardial perfusion. Background. In patients w
ith severe hypercholesterolemia, diet and lipid-lowering drugs are oft
en insufficient to achieve optimal LDL cholesterol values. Low density
lipoprotein apheresis is a very effective lipid-lowering therapy. Ass
essment of regional myocardial perfusion enables evaluation of the fun
ctional state of the coronary circulation. Methods. We studied 42 pati
ents with severe hypercholesterolemia and extensive coronary artery di
sease who were randomized to diet and simvastatin with or without biwe
ekly LDL apheresis. Regional myocardial perfusion was assessed by digi
tal subtraction angiography with videodensitometric calculation of hyp
eremic mean transit time (HMTT) of contrast medium at baseline and aft
er 2 years of therapy. Results. Low density lipoprotein cholesterol de
creased by 63% (to 3.0 mmol/liter) in the LDL apheresis group and by 4
7% (to 4.1 mmol/liter) in the medication group. Paired HMTT measuremen
ts were assessed in 43 regions in the LDL apheresis group and 35 regio
ns in the medication group, In the LDL apheresis group, regional HMTT
decreased over 2 years from 3.35 +/- 1.18 (mean +/- SDI to 2.87 +/- 0.
82 s (-14%, p = 0.001), whereas no change in the medication group was
observed: 2.95 +/- 1.06 to 2.96, +/- 0.90 s (p = NS), In the patient-b
ased comparison, the mean change in HMTT was -0.45 s (-14%, p = 0,01)
in the LDL apheresis group and -0.05 s (-2% p = NS) in the medication
group, respectively, Only exercise-induced ischemia improved in the LD
L apheresis group, Conclusions. Biweekly LDL apheresis plus simvastati
n decreased time-averaged LDL cholesterol le,els by an additional 31%
(1.1 mmol/liter) compared with medication alone, After 2 years of ther
apy, regional myocardial perfusion improved in the LDL apheresis group
and remained unchanged in the medication group, Thus, aggressive redu
ction of LDL cholesterol has a favorable effect on regional myocardial
perfusion and alleviates ischemia. (C) 1996 by the American College o
f Cardiology